Interaction with beta-arrestin determines the difference in internalization behavor between beta1- and beta2-adrenergic receptors
about
Proteomic analysis of beta1-adrenergic receptor interactions with PDZ scaffold proteinsDeterminants Present in the Receptor Carboxy Tail Are Responsible for Differences in Subtype-Specific Coupling of beta-Adrenergic Receptors to Phosphoinositide 3-Kinase.Molecular Signature That Determines the Acute Tolerance of G Protein-Coupled ReceptorsPhosphodiesterase 4D is required for beta2 adrenoceptor subtype-specific signaling in cardiac myocytesbeta-Arrestin-dependent activation of Ca(2+)/calmodulin kinase II after beta(1)-adrenergic receptor stimulation.Human beta1-adrenergic receptor is subject to constitutive and regulated N-terminal cleavageDifferential regulation of two palmitoylation sites in the cytoplasmic tail of the beta1-adrenergic receptorPhosphorylation of serine 1928 in the distal C-terminal domain of cardiac CaV1.2 channels during beta1-adrenergic regulation.Protein-protein interactions at the adrenergic receptors.Sustained βAR Stimulation Mediates Cardiac Insulin Resistance in a PKA-Dependent Manner.β-Arrestin drives MAP kinase signalling from clathrin-coated structures after GPCR dissociation.Phosphodiesterase 4 and phosphatase 2A differentially regulate cAMP/protein kinase a signaling for cardiac myocyte contraction under stimulation of beta1 adrenergic receptor.β-Adrenergic Receptor and Insulin Resistance in the Heart.GPCR Signaling and Trafficking: The Long and Short of It.Clathrin required for phosphorylation and internalization of beta2-adrenergic receptor by G protein-coupled receptor kinase 2 (GRK2).Receptor activity-independent recruitment of betaarrestin2 reveals specific signalling modes.Resistance of the human beta1-adrenergic receptor to agonist-induced ubiquitination: a mechanism for impaired receptor degradation.Clathrin box in G protein-coupled receptor kinase 2.Resistance of the human beta 1-adrenergic receptor to agonist-mediated down-regulation. Role of the C terminus in determining beta-subtype degradation.The myocardium-protective Gly-49 variant of the beta 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation.Activation mechanism of Gi and Go by reactive oxygen species.Antidepressant-induced switch of beta 1-adrenoceptor trafficking as a mechanism for drug action.Pharmacological characterization of putative beta1-beta2-adrenergic receptor heterodimers.Clenbuterol Induces Cell Cycle Arrest in C2C12 Myoblasts by Delaying p27 Degradation through β-arrestin 2 Signaling.Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G-protein and arrestin coupling.Functional selectivity of GPCR-directed drug action through location bias.Anti-beta1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease.Regulation of β2-adrenergic receptor cell surface expression by interaction with cystic fibrosis transmembrane conductance regulator-associated ligand (CAL).Carvedilol Prevents Redox Inactivation of Cardiomyocyte Β-Adrenergic Receptors
P2860
Q24297397-5669F147-FDAE-4A55-A212-0BDB03156F8CQ33602615-09FBFF3C-4DC0-4BCC-B1A1-847A5D4E7E42Q33655870-F4FEC033-9EDA-4D7C-B76C-7E1966CA7778Q33719524-F3AE3017-060E-4182-AAAF-4943785657DCQ33840022-9FBFA6D6-0EB1-4D75-9E20-292E984D2D4DQ34121376-D45B2710-5660-47B2-8F4D-84352542008CQ34998252-99C9214E-D25D-4BE0-A3A0-698B9803C603Q35133919-C1FC093F-1454-4216-B25F-2F60FA2AB827Q35791490-0CAF6A27-134C-45AB-9B2F-C66559CF852BQ36415798-3B86613E-2CEF-4D53-9F6D-88D60962EADBQ36619784-75E4455B-6816-4934-93E1-0E4FE6528444Q37125705-F371BEC6-CAE4-4415-B04F-8EFC049E4A54Q37551918-78E47AD0-41F8-48D2-B727-21B363CDE2BCQ39020873-B263EE02-0EF0-4857-B9E3-D3673328F188Q40241730-9B1F1DCB-AAC8-44A4-B6F7-05EA42C26423Q40251292-1FB6917E-5FBA-4AE5-8A49-A43BAA3EEFEEQ40522065-320E3095-6D2B-4BD9-9A3D-3493AB03334DQ40801655-0BFE8F61-018A-4AA4-8F3D-60CC1FB12A73Q42445328-CD6823D8-1A59-4D27-94FA-AC6961841E8FQ42521824-8D361A2C-FBA4-4DD9-999B-6EA828CDFE8DQ43847796-C87EBC98-0715-4372-8F87-7CF5AACEBC04Q44189940-D503666A-5FE7-4DC8-82B3-5AF542646D72Q44413518-9F4752E9-B0CA-4D49-AA65-6F2725C02874Q44510653-CE84AB3C-E5E8-45AA-971A-4CC218C50D6DQ45227106-0DFDDCC7-4FB1-45C6-A0F7-1133AAF91F35Q46765399-1245EEAE-B0E8-4D6E-94FD-DA5104680EDEQ51798355-0E23D0FA-9305-4268-8040-FFB3C02643ACQ55061344-2B7E772B-BBBA-44EF-8057-3C8190B68794Q58698747-53D03F60-C0D6-497D-AA8A-44D7665A369B
P2860
Interaction with beta-arrestin determines the difference in internalization behavor between beta1- and beta2-adrenergic receptors
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Interaction with beta-arrestin ...... and beta2-adrenergic receptors
@ast
Interaction with beta-arrestin ...... and beta2-adrenergic receptors
@en
Interaction with beta-arrestin ...... and beta2-adrenergic receptors
@nl
type
label
Interaction with beta-arrestin ...... and beta2-adrenergic receptors
@ast
Interaction with beta-arrestin ...... and beta2-adrenergic receptors
@en
Interaction with beta-arrestin ...... and beta2-adrenergic receptors
@nl
prefLabel
Interaction with beta-arrestin ...... and beta2-adrenergic receptors
@ast
Interaction with beta-arrestin ...... and beta2-adrenergic receptors
@en
Interaction with beta-arrestin ...... and beta2-adrenergic receptors
@nl
P2093
P2860
P356
P1476
Interaction with beta-arrestin ...... and beta2-adrenergic receptors
@en
P2093
P2860
P304
P356
10.1074/JBC.M909757199
P407
P577
2000-09-15T00:00:00Z